Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias
- 1Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- 2Instituto de Nutrição Josué de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
A Corrigendum on
Metabolic Reprogramming During Multidrug Resistance in Leukemias
by Vidal, R. S., Quarti, J., Rodrigues, M. F., Rumjanek, F. D., and Rumjanek, V. M. (2018). Front. Oncol. 8:90. doi: 10.3389/fonc.2018.00090
Mariana Figueiredo Rodrigues was not included as an author in the published article. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: multidrug resistance, glycolysis, glyceraldehyde-3-phosphate dehydrogenase, leukemia, reactive oxygen species
Citation: Vidal RS, Quarti J, Rodrigues MF, Rumjanek FD and Rumjanek VM (2018) Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias. Front. Oncol. 8:441. doi: 10.3389/fonc.2018.00441
Received: 20 September 2018; Accepted: 21 September 2018;
Published: 12 November 2018.
Approved by:Frontiers in Oncology Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2018 Vidal, Quarti, Rodrigues, Rumjanek and Rumjanek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vivian M. Rumjanek, email@example.com